Interferon alpha approved for Kaposi's sarcoma.
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D000328:Adult; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
D007370:Interferon Type I; D011994:Recombinant Proteins